InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by MOCH KENNETH I, Director. Director active across 2 companies, notably Zynerba Pharmaceuticals, Inc.. In total, 9 reports have been published. Activity tracked since 3 August 2021. The latest transaction was filed on 31 January 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
200,000 shares0Ordinary SharesSEC:0001415889-24-002346:0
28,300 shares0Ordinary SharesSEC:0001209191-23-053260:0
27,954 sharesCommon StockSEC:0001140361-23-047725:0
47,824 shares0Common StockSEC:0001062993-23-013667:0
28,300 shares0Ordinary SharesSEC:0001209191-23-008548:0
2,000 shares0Ordinary SharesSEC:0001209191-22-058393:0
23,109 shares0Common StockSEC:0001062993-22-015039:0
5,000 shares0Common StockSEC:0001192482-21-000642:0
5,000 shares0Common StockSEC:0001192482-21-000642
9 of 9 declarations
About MOCH KENNETH I
Kenneth I. Moch serves as a Director of Zynerba Pharmaceuticals, Inc. He provides strategic expertise to the board of directors, contributing to governance and key decision-making for the company. His experience in the pharmaceutical sector is an asset to the organization.
